|1.||Ohno, Naohito: 4 articles (04/2008 - 01/2003)|
|2.||Chen, Jiezhong: 3 articles (06/2013 - 06/2007)|
|3.||Yan, Jun: 3 articles (06/2009 - 06/2005)|
|4.||Gordon, Siamon: 3 articles (04/2005 - 02/2004)|
|5.||Brown, Gordon D: 3 articles (04/2005 - 02/2004)|
|6.||Kahramansoy, Nurettin: 2 articles (02/2012 - 07/2011)|
|7.||Kordon, Ozgür: 2 articles (02/2012 - 07/2011)|
|8.||Erkol, Hayri: 2 articles (02/2012 - 07/2011)|
|9.||Limper, Andrew H: 2 articles (08/2010 - 07/2003)|
|10.||Kevelaitis, Egidijus: 2 articles (04/2010 - 01/2007)|
03/15/2009 - "To our knowledge, this is the first in vivo study, in which the use of beta-glucans as feed ingredient for just-weaned piglets was tested for their protective effects against ETEC infection."
03/15/2009 - "This study showed that beta-glucans can protect against an ETEC infection. "
03/15/2009 - "The effect of orally administered beta-glucans in protecting pigs against an ETEC infection after weaning was analysed in this study. "
02/01/2005 - "In-vitro and animal studies suggest that beta-glucans shift inflammatory profiles to a Th1 type, which may enhance resistance against bacterial and parasitic infections. "
01/01/2014 - "Yeast-derived beta-glucans (Y-BG) are considered immunomodulatory compounds suggested to enhance the defense against infections and exert anticarcinogenic effects. "
06/01/2013 - "In addition, mushroom extracts with high levels of beta-glucans have also been shown to have direct cytotoxic effects on cancer cells, and beta-glucans are used for the treatment of cancer. "
03/01/2010 - "Due to their immunomodulatory properties, purified beta-glucans have been used clinically as part of a combination therapy for a variety of cancers and their potential anti-infective properties have received attention. "
01/01/2010 - "Concomitantly, the role of beta-glucans as chemoimmunotherapeutic in a number of solid cancers has been widely documented. "
01/01/2009 - "So far, no good quality clinical trial data is available on assessing the effectiveness of purified beta-glucans among cancer patients. "
03/01/2008 - "beta-Glucans in promoting health: prevention against mutation and cancer."
|3.||Obstructive Jaundice (Cholestatic Jaundice)
02/01/2015 - "The present study showed a positive effect of beta-glucans, especially the low molecular weight form, on the colon tissue of healthy rats, as well as animals with LPS-induced enteritis."
02/01/2015 - "The effect of low or high molecular weight oat beta-glucans on the inflammatory and oxidative stress status in the colon of rats with LPS-induced enteritis."
02/01/2015 - "The positive influence of beta-glucans was also manifested by the improved values of antioxidative potential markers (TAS, SOD, GR and GPx activity, TBARS concentration), noted especially in rats with LPS-induced enteritis. "
|5.||Colonic Neoplasms (Colon Cancer)
06/01/2013 - "Beta-glucans can also have synergistic effects with chemotherapeutic agents and other immune stimulators, and an innovative strategy is to use beta-glucans to deliver nanoparticles containing chemotherapeutic agents to the site of the colon cancer and, thus, improve the therapeutic efficacy."
06/01/2013 - "This review summarizes the use of beta-glucans in colon cancer. "
06/01/2013 - "Evidence has supported the idea that beta-glucans can decrease the size of xenografted colon cancer tumors via the stimulation of the immune system and direct cytotoxicity. "
|1.||Thiobarbituric Acid Reactive Substances
|3.||Immunologic Factors (Immunomodulators)
|4.||Complement C3b (C3bi)
|7.||Toll-Like Receptors (Toll-Like Receptor)
|8.||Macrophage-1 Antigen (Macrophage 1 Antigen)
|1.||Drug Therapy (Chemotherapy)
|3.||Photochemotherapy (Photodynamic Therapy)